BTK and Miyoshi myopathy: In multiple myeloma (MM), a malignancy of plasma cells in the bone marrow, BTK was shown to be overexpressed, whereby BTK activated AKT signaling, leading to down-regulation of P27 expression and upregulation of key stemness genes [179, 180].